Be The First To
Cortex Pharmaceuticals develops drugs to treat neurodegenerative and psychiatric disorders. Its research focuses on the AMPA receptor, which facilitates communication between nerve cells; the firm's Ampakine compounds may enhance this receptor's activity. Cortex's tends to develop candidates and then license the technologies to larger firms for diseases that require clinical and commercialization infrastructure to develop drugs for large markets (Alzheimer's disease, for instance). In turn, it will focus its internal research efforts on developing more compounds for niche...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Let us know if we're missing any workplace or industry recognition –